Journal ArticleDOI
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens.
Luca Chiovato,Francesco Latrofa,Lewis E. Braverman,Furio Pacini,Marco Capezzone,Lucio Masserini,Lucia Grasso,Aldo Pinchera +7 more
Reads0
Chats0
TLDR
A large group of patients with differentiated thyroid carcinoma who had serum thyroid peroxidase, thyroglobulin, or TSH-receptor antibodies due to coexistent thyroid autoimmune disease were studied, finding gradual disappearance of antibodies gradually disappeared in most patients.Abstract:
Le malattie autoimmuni della tiroide sono caratterizzate dalla presenza di anticorpi diretti contro la tireoperossidasi (TPO), la tireoglobulina (Tg) e il recettore per l’ormone tireotropo (TSH-R). Questo studio ha valutato se la rimozione completa degli antigeni tiroidei fosse in grado di indurre la scomparsa dei segni di autoimmunita tiroidea circolante. Lo studio e basato su una revisione retrospettiva delle cartelle cliniche di pazienti che erano stati seguiti e trattati secondo un protocollo standard. Sono stati studiati 182 pazienti affetti da tumore differenziato della tiroide i quali, per la coesistenza di una tiroidite cronica autoimmune, di un morbo di Basedow o di una tiroidite focale autoimmune, risultavano positivi per anticorpi anti-TPO (TPOAb), anti-Tg (TgAb) o anti-TSH-R (TRAb). Dei 182 soggetti, 151 erano di sesso femminile e 31 di sesso maschile; l’eta media era di 39,7±13,7 anni, con un range da 6 a 81 anni. Tutti i pazienti sono stati sottoposti a tiroidectomia totale e a trattamento con iodio radioattivo allo scopo di ablare il tessuto tiroideo residuo o metastatico. Il follow-up e stato effettuato mediante scintigrafie corporee totali con radioiodio e dosaggio della Tg circolante. La media del follow-up era di 10,1±4,1 anni, con un range di 4–20 anni. A seguito del trattamento con tiroidectomia totale e iodio radioattivo, si e verificata la scomparsa dei TgAb, TPOAb e TRAb. La mediana di scomparsa e stata di 6,3 anni per iTPOAb e di 3,0 anni per i TgAb. La scomparsa del tessuto tiroideo e quella degli anticorpi antitiroide erano correlate in modo statisticamente significativo. La persistenza di TPOAb e TgAb non veniva influenzata dal sesso, dall’eta e dalla concomitanza della tiroidite autoimmune o del morbo di Basedow.read more
Citations
More filters
Journal ArticleDOI
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R. Haugen,Erik K. Alexander,Keith C. Bible,Gerard M. Doherty,Susan J. Mandel,Yuri E. Nikiforov,Furio Pacini,Gregory W. Randolph,Anna M. Sawka,Martin Schlumberger,Kathryn G. Schuff,Steven I. Sherman,Julie Ann Sosa,David L. Steward,R. Michael Tuttle,Leonard Wartofsky +15 more
TL;DR: Evidence-based recommendations are developed to inform clinical decision-making in the management of thyroid nodules and differentiated thyroid cancer and represent, in the authors' opinion, contemporary optimal care for patients with these disorders.
Journal ArticleDOI
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper,Gerard M. Doherty,Bryan R. Haugen,Richard T. Kloos,Stephanie L. Lee,Susan J. Mandel,Ernest L. Mazzaferri,Bryan McIver,Furio Pacini,Martin Schlumberger,Steven I. Sherman,David L. Steward,R. Michael Tuttle +12 more
TL;DR: Evidence-based recommendations in response to the appointment as an independent task force by the American Thyroid Association to assist in the clinical management of patients with thyroid nodules and differentiated thyroid cancer represent, in the authors' opinion, contemporary optimal care for patients with these disorders.
Journal ArticleDOI
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
Journal ArticleDOI
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Furio Pacini,Martin Schlumberger,Henning Dralle,Rossella Elisei,Johannes W. A. Smit,Wilmar M. Wiersinga +5 more
TL;DR: European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium Furio Pacini, Martin Schlumberger, Henning Dralle, Rossella Elisei, Johannes W A Smit, Wilmar Wiersinga and the European Thyroid Cancer Taskforce Section of Endocrinology and Metabolism are presented.
Journal ArticleDOI
Competence and competition : the challenge of becoming a long-lived plasma cell
Andreas Radbruch,Gwendolin Muehlinghaus,Elke Luger,Ayako Inamine,Kenneth G. C. Smith,Thomas Dörner,Falk Hiepe +6 more
TL;DR: Studies of the biology of plasma cells reveal a mechanism of intriguing simplicity and elegance that focuses memory provided by plasma cells on recently encountered pathogens while minimizing the 'fading' of memory for pathogens encountered in the distant past.
References
More filters
Journal ArticleDOI
Autoimmune thyroid disease: further developments in our understanding
Anthony P. Weetman,A.M. McGregor +1 more
TL;DR: The revolution in molecular techniques has allowed dissection of the autoimmune response in a way impossible to imagine 10 yr ago, but there have been no really major improvements in the understanding of the immunogenetics of thyroid autoimmunity, equivalent to those made in type 1 diabetes mellitus.
Journal ArticleDOI
The thyroid : a fundamental and clinical text
TL;DR: This book is an important reference text on the thyroid gland for workers in a wide variety of disciplines and will be disappointing to doctors currently setting up in vitro laboratory techniques for nuclear medicine.
Journal ArticleDOI
Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Carole A. Spencer,M Takeuchi,M. Kazarosyan,C. C. Wang,Richard B. Guttler,Peter Singer,Shireen Fatemi,Jonathan S. LoPresti,John T. Nicoloff +8 more
TL;DR: The RIA method used in this study provided more clinically appropriate serum Tg values in the group of TgAb-positive patients with metastatic DTC and may be an additional clinically useful tumor marker parameter for following T gAb- positive patients.
Journal ArticleDOI
Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation
June-Key Chung,Young Joo Park,Tae Yong Kim,Young So,Sungkyoon Kim,Do Joon Park,Dong Soo Lee,Myung Chul Lee,Byung-Kyu Cho +8 more
TL;DR: This study was designed to investigate whether an elevated serum antithyroglobulin antibody (TgAb) reflects cancer recurrence in thyrogLobulin (TG)‐undetectable patients with differentiated thyroid carcinoma (DTC) after thyroid ablation.
Journal ArticleDOI
Surgical treatment of graves' disease: Subtotal or total thyroidectomy?†
Paolo Miccoli,Paolo Vitti,Teresa Rago,Pietro Iacconi,Luigi Bartalena,Fausto Bogazzi,Emilio Fiore,Rocco Valeriano,Luca Chiovato,Roberto Rocchi,Aldo Pinchera +10 more
TL;DR: Total thyroidectomy does not present more complications with respect to subtotal thyroidectomy, but it avoids the worsening of thyroid humoral autoimmunity and the relapse of hyperthyroidism, so it could represent the treatment of choice in Graves' disease.